Your browser doesn't support javascript.
loading
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia.
Wang, Yu-Hung; Lin, Chien-Chin; Gurashi, Kristian; Yao, Chi-Yuan; Jerez, Andres; Hou, Hsin-An; Chou, Wen-Chien; Tien, Hwei-Fang; Batta, Kiran; Wiseman, Daniel H.
Afiliação
  • Wang YH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK.
  • Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Gurashi K; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Yao CY; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Jerez A; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK.
  • Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Chou WC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Tien HF; Haematology Department, Hospital Morales Meseguer, Murcia, Spain.
  • Batta K; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
  • Wiseman DH; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
Blood Cancer J ; 14(1): 112, 2024 Jul 12.
Article em En | MEDLINE | ID: mdl-38997261

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielomonocítica Crônica / Proteína Supressora de Tumor p53 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielomonocítica Crônica / Proteína Supressora de Tumor p53 Idioma: En Ano de publicação: 2024 Tipo de documento: Article